Survodutide is a dual agonist at the GLP-1 and glucagon receptors, studied in metabolic research models for the way it engages two pathways at once. This overview is a sourcing and handling reference for HPLC-verified labs.
The dual-agonist mechanism
Single-pathway incretin agonists act at the GLP-1 receptor alone. Survodutide adds glucagon-receptor activity, and the research interest centers on how the balance between the two arms behaves in metabolic models. It sits in the same class discussion as the tri-agonist retatrutide, see our retatrutide pharmacology overview for the multi-receptor context.
Where purity enters
Multi-receptor peptides are long and sequence-sensitive, so synthesis impurities are both more likely and more consequential. A lot that clears the 99% HPLC floor and carries a mass-spec identity confirmation removes a major source of assay noise. Pure North archives every lot's Janoshik COA at /lab-results/.
Handling and storage
Store the lyophilized vial dry at −20 °C. Reconstitute in sterile bacteriostatic water at the working concentration your protocol specifies; our calculator converts vial size and target concentration to an exact diluent volume. Aliquot before freezing and avoid repeated freeze-thaw cycles.
Identity before signal
For a dual agonist, confirm identity by mass spec before reading any downstream result, purity tells you how clean the sample is, identity tells you it is survodutide at all. Both are on the COA.
Sourcing in Canada
Canadian-based, shipped domestic via Canada Post Xpresspost, dispatched within 24-48 hours, ~4 days transit, free over $200 CAD, paid by Interac e-Transfer or Bitcoin. Browse the catalog. Supplied as a reference standard for laboratory research use only.